CompletedNot Applicable

Evaluation of the Triamcinolone -Acetonide Therapy for the Treatment of the Medial Plica Syndrome

Italy30 participantsStarted 2021-10-28

Plain-language summary

The aim of this pilot study is to evaluate the clinical and radiological outcomes (ultrasound and MRI) for a treatment utilized in the medial plica syndrome resistant to conservative therapy. Will be evaluated an intra-plica ultrasound-guided injections of Triamcinolone-Acetonide and lidocaine percutaneously, and associated rehabilitation therapy. The aim of the study will be to evaluate the efficacy and safety of the injection procedure by revealing clinical improvement and monitoring the incidence of adverse events following treatment.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Ultrasonographic and/or MRI signs of medial plica pathology;
✓. VAS pain 4-8 at time of inclusion;
✓. Failure, defined as the persistence of symptomatology, after at least one course of conservative treatment of at least 6 weeks (rest and drug treatment, physiotherapy);
✓. Ability and consent of patients to actively participate in clinical follow-up;

Exclusion criteria

✕. BMI \> 35;
✕. Patients with: rheumatic diseases, diabetes, infectious processes, epilepsy, severe stage osteoporosis
✕. Patients undergoing intra-tendon infiltration of other substance within the previous 6 months;
✕. Patients undergoing surgery on the affected knee within the previous 12 months;
✕. Patients undergoing femoro- patellar joint stabilization surgery to the affected knee;
✕. Trauma to the affected knee within the past 6 months;
✕. Episodes of patellar dislocation and subluxation to the affected knee;
✕. State of immunodepression;

What they're measuring

KUJALA Scale (Kujala Anterior Knee Pain Scale (AKPS

Timeframe: 6 months FU

Trial details

NCT IDNCT04943341

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-16

View on ClinicalTrials.gov More Medial Plica Syndrome trials